CIK 0001001233
- Non-accelerated filer
- Smaller reporting company
SANGAMO THERAPEUTICS, INC
Sign in to watch- Ticker
- SGMOQ
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680359556
- Phone
- +1 510-970-6000
- Business address
- 501 CANAL BLVD., RICHMOND, CA, 94084
- Former names
- SANGAMO BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-25 | McClung David Mark EVP, Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +160,380 | 160,380 | ||
| 2022-02-25 | Macrae Sandy President, CEO and Director | Shares withheld for taxes | −49,890 | $5.90 | $294K | 297,176 |
| 2022-02-25 | Macrae Sandy President, CEO and Director | Grant or award | +224,000 | 521,176 | ||
| 2022-02-25 | Macrae Sandy President, CEO and Director | Grant or award · Stock Option (Right to Buy) | +604,800 | 604,800 | ||
| 2022-02-25 | Zakrzewski Joseph S Director | Grant or award | +12,500 | 60,700 | ||
| 2022-02-25 | Zakrzewski Joseph S Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-02-25 | Smith Karen L. Director | Grant or award | +12,500 | 38,200 | ||
| 2022-02-25 | Smith Karen L. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-02-25 | Ramasastry Saira Director | Grant or award | +12,500 | 35,700 | ||
| 2022-02-25 | Ramasastry Saira Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-02-25 | PARKER H STEWART Director | Grant or award | +12,500 | 43,700 | ||
| 2022-02-25 | PARKER H STEWART Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-02-25 | Meyers James R Director | Grant or award | +12,500 | 35,700 | ||
| 2022-02-25 | Meyers James R Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-02-25 | Markels John Director | Grant or award | +12,500 | 25,700 | ||
| 2022-02-25 | Markels John Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-02-25 | Hillan Kenneth J. Director | Grant or award | +12,500 | 35,700 | ||
| 2022-02-25 | Hillan Kenneth J. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-02-25 | Carey Robert Director | Grant or award | +12,500 | 35,700 | ||
| 2022-02-25 | Carey Robert Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 14 of 17 · 338 trades